Search results
Showing 1 to 7 of 7 results for insulin degludec
Summary of the evidence on insulin degludec for treating type 2 diabetes to inform local NHS planning and decision-making
Type 2 diabetes: insulin degludec/liraglutide (Xultophy) (ESNM60)
Summary of the evidence on insulin degludec/liraglutide (Xultophy) for treating type 2 diabetes to inform local NHS planning and decision-making
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
Evidence-based recommendations on tirzepatide (Mounjaro) for type 2 diabetes in adults.
This evidence summary has been updated and replaced by NICE guideline NG17.
This evidence summary has been updated and replaced by NICE advice ESNM25.
This evidence summary has been updated and replaced by NICE advice ESNM24.